4.7 Article

Genomic Screening of Antimicrobial Resistance Markers in UK and US Campylobacter Isolates Highlights Stability of Resistance over an 18-Year Period

期刊

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/aac.01687-21

关键词

antimicrobial resistance; antibiotic stewardship; Campylobacter; surveillance; quinolones; tetracycline; aminoglycosides; macrolides; whole-genome sequencing; surveillance studies

资金

  1. European Union [773830]
  2. National Institutes of Health/Food and Drug Administration [5U19FD007113-02]
  3. UK Food Standards Agency
  4. Wellcome Trust

向作者/读者索取更多资源

This study compared the prevalence and trends of antimicrobial resistance (AMR) in Campylobacter isolated in the UK and US between 2001 and 2018 through genome sequencing analysis. The results showed significant differences in AMR prevalence between the two countries, suggesting that antimicrobial stewardship and restricted antibiotic usage may help contain the further expansion of AMR but are unlikely to reduce it in the short term.
Campylobacter jejuni and Campylobacter coil are important bacterial causes of human foodborne illness. Despite several years of reduced antibiotics usage in livestock production in the United Kingdom (UK) and United States (US), a high prevalence of antimicrobial resistance (AMR) persists in Campylobacter. Both countries have instigated genome sequencing-based surveillance programs for Campylobacter, and in this study, we have identified AMR genes in 32,256 C. jejuni and 8,776 C. coli publicly available genome sequences to compare the prevalence and trends of AMR in Campylobacter isolated in the UK and US between 2001 and 2018. AMR markers were detected in 68% of C. coil and 53% of C. jejuni isolates, with 15% of C. coli isolates being multidrug resistant (MDR), compared to only 2% of C. jejuni isolates. The prevalence of aminoglycoside, macrolide, quinolone, and tetracycline resistance remained fairly stable from 2001 to 2018 in both C. jejuni and C. coli, but statistically significant differences were observed between the UK and US. There was a statistically significant higher prevalence of aminoglycoside and tetracycline resistance for US C. coli and C. jejuni isolates and macrolide resistance for US C. coil isolates. In contrast, UK C. coli and C. jejuni isolates showed a significantly higher prevalence of quinolone resistance. Specific multilocus sequence type (MIST) clonal complexes (e.g., ST-353/464) showed >95% quinolone resistance. This large-scale comparison of AMR prevalence has shown that the prevalence of AMR remains stable for Campylobacter in the UK and the US. This suggests that antimicrobial stewardship and restricted antibiotic usage may help contain further expansion of AMR prevalence in Campylobacter but are unlikely to reduce it in the short term.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据